参考文献/References:
[1] MODJTAHEDI B S,FERRIS F L 3RD,HUNTER D G,FONG D S.Public health burden and potential interventions for myopia[J].Ophthalmology,2018,125(5):628-630.
[2] RESNIKOFF S,JONAS J B,FRIEDMAN D,HE M,JONG M,NICHOLS J J,et al.Myopia-a 21st century public health issue[J].Invest Ophthalmol Vis Sci,2019,60(3):Mi-Mii.
[3] MORGAN I G,FRENCH A N,ASHBY R S,GUO X,DING X,HE M,et al.The epidemics of myopia:Aetiology and prevention[J].Prog Retin Eye Res,2018,62:134-149.
[4] HOLDEN B A,FRICKE T R,WILSON D A,JONG M,NAIDOO K S,SANKARIDURG P,et al.Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050[J].Ophthalmology,2016,123(5):1036-1042.
[5] BAIRD P N,SAW S M,LANCA C,GUGGENHEIM J A,SMITH III E L,ZHOU X,et al.Myopia[J].Nat Rev Dis Primers,2020,6(1):99.
[6] ZHOU X,PARDUE M T,IUVONE P M,QU J.Dopamine signaling and myopia development:what are the key challenges[J].Prog Retin Eye Res,2017,61:60-71.
[7] GAO Q,LIU Q,MA P,ZHONG X,WU J,GE J.Effects of direct intravitreal dopamine injections on the development of lid-suture induced myopia in rabbits[J].Graefes Arch Clin Exp Ophthalmol,2006,244(10):1329-1335.
[8] THOMSON K,KAROUTA C,ASHBY R.Form-deprivation and lens-induced myopia are similarly affected by pharmacological manipulation of the dopaminergic system in chicks[J].Invest Ophthalmol Vis Sci,2020,61(12):4.
[9] PILTONEN M,PLANKEN A,LESKEL O,MYHNEN T T,HNNINEN A L,AUVINEN P,et al.Vascular endothelial growth factor c acts as a neurotrophic factor for dopamine neurons in vitro and in vivo[J].Neuroscience,2011,192:550-563.
[10] MATEO I,LLORCA J,INFANTE J,RODRGUEZ-RODRGUEZ E,FERNNDEZ-VIADERO C,PEA N,et al.Low serum VEGF levels are associated with alzheimer’s disease[J].Acta Neurol Scand,2007,116(1):56-58.
[11] MCBRIEN N A,COTTRIALL C L,ANNIES R.Retinal acetylcholine content in normal and myopic eyes:a role in ocular growth control?[J].Vis Neurosci,2001,18(4):571-580.
[12] DONG F,ZHI Z,PAN M,XIE R,QIN X,LU R,et al.Inhibition of experimental myopia by a dopamine agonist:Different effectiveness between form deprivation and hyperopic defocus in guinea pigs[J].Mol Vis,2011,17:2824-2834.
[13] MCCARTHY C S,MEGAW P,DEVADAS M,MORGAN I G.Dopaminergic agents affect the ability of brief periods of normal vision to prevent form-deprivation myopia[J].Exp Eye Res,2007,84(1):100-107.
[14] THOMSON K,MORGAN I,KAROUTA C,ASHBY R.Levodopa inhibits the development of lens-induced myopia in chicks[J].Sci Rep,2020,10(1):13242.
[15] HUPP-GOURGUES F,COUD G,LACHAPELLE P,CASANOVA C.Effects of the intravitreal administration of dopaminergic ligands on the b-wave amplitude of the rabbit electroretinogram[J].Vision Res,2005,45(2):137-145.
[16] ZHANG S,YANG J,REINACH P S,WANG F,ZHANG L,FAN M,et al.Dopamine receptor subtypes mediate opposing effects on form deprivation myopia in pigmented guinea pigs[J].Invest Ophthalmol Vis Sci,2018,59(11):4441-4448.
[17] BERGEN M A,PARK H N,CHAKRABORTY R,LANDIS E G,SIDHU C,HE L,et al.Altered refractive development in mice with reduced levels of retinal dopamine[J].Invest Ophthalmol Vis Sci,2016,57(10):4412-4419.
[18] OSINGA T E,LINKS T P,DULLAART R P F,PACAK K,VAN DER HORST-SCHRIVERS A N A,KERSTENS M N,et al.Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma[J].FASEB J,2017,31(6):2226-2240.
[19] MEGAW P,MORGAN I,BOELEN M.Vitreal dihydroxyphenylacetic acid (dopac) as an index of retinal dopamine release[J].J Neurochem,2001,76(6):1636-1644.
[20] FELDKAEMPER M,SCHAEFFEL F.An updated view on the role of dopamine in myopia[J].Exp Eye Res,2013,114:106-119.
[21] MELINCOVICI C S,BO CA A B, U MAN S,MRGINEAN M,MIHU C,ISTRATE M,et al.Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis[J].Rom J Morphol Embryol,2018,59(2):455-467.
[22] TARALLO V,DE FALCO S.The vascular endothelial growth factors and receptors family:up to now the only target for anti-angiogenesis therapy[J].Int J Biochem Cell Biol,2015,64:185-189.
[23] ECHEVERRIA V,BARRETO G E,AVILA-RODRIGUEZC M,TARASOV V V,ALIEV G.Is VEGF a key target of cotinine and other potential therapies against alzheimer disease?[J].Curr Alzheimer Res,2017,14(11):1155-1163.
[24] NISHIJIMA K,NG Y S,ZHONG L,BRADLEY J,SCHUBERT W,JO N,et al.Vascular endothelial growth factor-a is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury[J].Am J Pathol,2007,171(1):53-67.
[25] YASUHARA T,SHINGO T,KOBAYASHI K,TAKEUCHI A,YANO A,MURAOKA K,et al.Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of parkinson’s disease[J].Eur J Neurosci,2004,19(6):1494-1504.
[26] ZACHARY I.Neuroprotective role of vascular endothelial growth factor:signalling mechanisms,biological function,and therapeutic potential[J].Neurosignals,2005,14(5):207-221.
[27] CAI S,YANG Q,LI X,ZHANG Y.The efficacy and safety of aflibercpt and conbercept in diabetic macular edema[J].Drug Des Devel Ther,2018,12:3471-3483.